 Betsy Risendal
Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 18 | 2023 | 2870 | 1.910 |
Why?
| | Cancer Survivors | 5 | 2023 | 326 | 1.700 |
Why?
| | Patient Navigation | 4 | 2022 | 104 | 1.680 |
Why?
| | Survivors | 12 | 2015 | 516 | 1.460 |
Why?
| | Breast Neoplasms | 23 | 2022 | 2447 | 1.220 |
Why?
| | Colorectal Neoplasms | 7 | 2022 | 844 | 1.140 |
Why?
| | Community-Based Participatory Research | 2 | 2025 | 166 | 0.750 |
Why?
| | Delivery of Health Care | 8 | 2023 | 940 | 0.690 |
Why?
| | Health Plan Implementation | 3 | 2018 | 136 | 0.660 |
Why?
| | Early Detection of Cancer | 7 | 2023 | 462 | 0.560 |
Why?
| | Patient Care Planning | 4 | 2015 | 169 | 0.510 |
Why?
| | Patient Advocacy | 1 | 2017 | 73 | 0.500 |
Why?
| | Quality of Life | 4 | 2023 | 3166 | 0.430 |
Why?
| | Specialization | 1 | 2015 | 134 | 0.420 |
Why?
| | Research Design | 4 | 2025 | 1129 | 0.380 |
Why?
| | Physicians, Primary Care | 1 | 2015 | 206 | 0.380 |
Why?
| | Self Care | 1 | 2014 | 388 | 0.350 |
Why?
| | Registries | 2 | 2020 | 2382 | 0.350 |
Why?
| | Health Equity | 2 | 2023 | 129 | 0.320 |
Why?
| | Humans | 55 | 2025 | 144261 | 0.320 |
Why?
| | Mass Screening | 6 | 2022 | 1332 | 0.310 |
Why?
| | Health Knowledge, Attitudes, Practice | 5 | 2014 | 1409 | 0.300 |
Why?
| | Indians, North American | 3 | 1999 | 646 | 0.300 |
Why?
| | Patient-Centered Care | 1 | 2014 | 540 | 0.300 |
Why?
| | Chronic Disease | 2 | 2015 | 1812 | 0.300 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 706 | 0.300 |
Why?
| | Cross-Sectional Studies | 10 | 2020 | 5813 | 0.290 |
Why?
| | Weight Gain | 1 | 2013 | 556 | 0.290 |
Why?
| | Middle Aged | 29 | 2022 | 35762 | 0.270 |
Why?
| | Program Evaluation | 4 | 2022 | 946 | 0.270 |
Why?
| | Family Health | 1 | 2008 | 191 | 0.260 |
Why?
| | Logistic Models | 10 | 2019 | 2104 | 0.260 |
Why?
| | Aged | 21 | 2022 | 25850 | 0.260 |
Why?
| | Continuity of Patient Care | 3 | 2015 | 287 | 0.260 |
Why?
| | Surveys and Questionnaires | 9 | 2022 | 6021 | 0.250 |
Why?
| | Safety-net Providers | 2 | 2018 | 124 | 0.250 |
Why?
| | Quality of Health Care | 1 | 2011 | 688 | 0.240 |
Why?
| | Practice Patterns, Physicians' | 1 | 2015 | 1347 | 0.240 |
Why?
| | Capacity Building | 2 | 2023 | 58 | 0.230 |
Why?
| | Case-Control Studies | 7 | 2020 | 3592 | 0.230 |
Why?
| | Mammography | 3 | 2010 | 165 | 0.230 |
Why?
| | Intergenerational Relations | 1 | 2025 | 18 | 0.220 |
Why?
| | Female | 36 | 2025 | 77976 | 0.220 |
Why?
| | Primary Health Care | 4 | 2022 | 1710 | 0.220 |
Why?
| | Odds Ratio | 5 | 2013 | 1072 | 0.210 |
Why?
| | Survivorship | 2 | 2022 | 54 | 0.210 |
Why?
| | Arizona | 4 | 2013 | 81 | 0.210 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2014 | 267 | 0.200 |
Why?
| | Child Behavior | 1 | 2025 | 235 | 0.190 |
Why?
| | Adult | 25 | 2019 | 40262 | 0.190 |
Why?
| | Exercise | 1 | 2014 | 2193 | 0.180 |
Why?
| | Risk Factors | 13 | 2023 | 10699 | 0.170 |
Why?
| | Healthcare Disparities | 3 | 2017 | 725 | 0.160 |
Why?
| | United States | 14 | 2023 | 15876 | 0.160 |
Why?
| | Papanicolaou Test | 1 | 1999 | 35 | 0.150 |
Why?
| | Vaginal Smears | 1 | 1999 | 55 | 0.150 |
Why?
| | Health Priorities | 1 | 1999 | 42 | 0.150 |
Why?
| | Unemployment | 1 | 2019 | 41 | 0.140 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2637 | 0.140 |
Why?
| | Research | 3 | 2018 | 428 | 0.140 |
Why?
| | Patient Education as Topic | 2 | 2014 | 777 | 0.130 |
Why?
| | Congresses as Topic | 1 | 2019 | 221 | 0.130 |
Why?
| | Age Factors | 7 | 2019 | 3313 | 0.130 |
Why?
| | Preventive Medicine | 1 | 2017 | 39 | 0.120 |
Why?
| | Follow-Up Studies | 3 | 2015 | 5389 | 0.120 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 235 | 0.120 |
Why?
| | Public Health | 1 | 2021 | 564 | 0.120 |
Why?
| | Health Planning | 1 | 2015 | 47 | 0.110 |
Why?
| | Comorbidity | 1 | 2020 | 1646 | 0.110 |
Why?
| | Health Status | 1 | 2020 | 833 | 0.110 |
Why?
| | Community Health Centers | 1 | 2014 | 59 | 0.110 |
Why?
| | Pediatric Obesity | 1 | 2022 | 624 | 0.110 |
Why?
| | Diagnostic Tests, Routine | 1 | 2015 | 108 | 0.100 |
Why?
| | Anniversaries and Special Events | 1 | 2014 | 16 | 0.100 |
Why?
| | Disease Management | 2 | 2015 | 643 | 0.100 |
Why?
| | Transition to Adult Care | 1 | 2015 | 94 | 0.100 |
Why?
| | Diffusion of Innovation | 1 | 2014 | 97 | 0.100 |
Why?
| | Health Behavior | 1 | 1999 | 782 | 0.100 |
Why?
| | Patient Acceptance of Health Care | 2 | 2018 | 878 | 0.100 |
Why?
| | Body Weight | 2 | 2013 | 976 | 0.100 |
Why?
| | Colorado | 4 | 2025 | 4562 | 0.100 |
Why?
| | Ambulatory Care Facilities | 1 | 2015 | 264 | 0.100 |
Why?
| | Health Promotion | 2 | 2023 | 774 | 0.100 |
Why?
| | Age of Onset | 2 | 2019 | 536 | 0.090 |
Why?
| | New Mexico | 1 | 2013 | 98 | 0.090 |
Why?
| | Vitamin B Complex | 1 | 2013 | 40 | 0.090 |
Why?
| | Genetic Testing | 1 | 2015 | 478 | 0.090 |
Why?
| | Incidence | 4 | 2019 | 2870 | 0.090 |
Why?
| | Receptors, Estrogen | 3 | 2013 | 457 | 0.090 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2012 | 35 | 0.090 |
Why?
| | Medical Oncology | 1 | 2015 | 331 | 0.090 |
Why?
| | Methionine | 1 | 2013 | 162 | 0.090 |
Why?
| | Socioeconomic Factors | 4 | 2013 | 1312 | 0.090 |
Why?
| | Health Personnel | 1 | 2018 | 742 | 0.090 |
Why?
| | Male | 8 | 2025 | 72035 | 0.090 |
Why?
| | Folic Acid | 1 | 2013 | 199 | 0.090 |
Why?
| | Prognosis | 3 | 2022 | 4278 | 0.080 |
Why?
| | Patient Participation | 1 | 2014 | 429 | 0.080 |
Why?
| | Guideline Adherence | 1 | 2015 | 586 | 0.080 |
Why?
| | Obesity | 3 | 2013 | 3057 | 0.080 |
Why?
| | Patient Satisfaction | 1 | 2015 | 704 | 0.080 |
Why?
| | Health Services Accessibility | 2 | 2014 | 1091 | 0.080 |
Why?
| | Feasibility Studies | 1 | 2014 | 1087 | 0.080 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 32 | 0.080 |
Why?
| | Survival Rate | 2 | 2011 | 2088 | 0.080 |
Why?
| | Southwestern United States | 4 | 2011 | 95 | 0.080 |
Why?
| | Hydroxyestrones | 1 | 2009 | 2 | 0.070 |
Why?
| | Interviews as Topic | 2 | 2013 | 898 | 0.070 |
Why?
| | Patient Care Team | 1 | 2014 | 686 | 0.070 |
Why?
| | Confidence Intervals | 1 | 2008 | 333 | 0.070 |
Why?
| | Cohort Studies | 2 | 2022 | 5935 | 0.070 |
Why?
| | Urinary Incontinence | 1 | 2008 | 64 | 0.070 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2009 | 319 | 0.060 |
Why?
| | Prospective Studies | 2 | 2025 | 7970 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2014 | 1559 | 0.060 |
Why?
| | Parity | 2 | 2022 | 109 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 1999 | 1533 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 3 | 2010 | 2359 | 0.060 |
Why?
| | Patient Compliance | 1 | 2009 | 585 | 0.060 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2025 | 132 | 0.050 |
Why?
| | Reproducibility of Results | 3 | 2018 | 3403 | 0.050 |
Why?
| | Smoking | 2 | 2023 | 1468 | 0.050 |
Why?
| | Psychometrics | 2 | 2018 | 730 | 0.050 |
Why?
| | Phenotype | 1 | 2011 | 3157 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2009 | 1313 | 0.050 |
Why?
| | School Teachers | 1 | 2022 | 29 | 0.040 |
Why?
| | Parenting | 1 | 2025 | 317 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2012 | 2516 | 0.040 |
Why?
| | Young Adult | 4 | 2019 | 13990 | 0.040 |
Why?
| | Child Development | 1 | 2025 | 484 | 0.040 |
Why?
| | Postpartum Period | 1 | 2022 | 361 | 0.040 |
Why?
| | Financing, Personal | 1 | 2019 | 27 | 0.040 |
Why?
| | School Health Services | 1 | 2022 | 224 | 0.040 |
Why?
| | Alcohol Drinking | 2 | 2011 | 812 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2007 | 1092 | 0.040 |
Why?
| | Culture | 1 | 1999 | 125 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2022 | 1322 | 0.040 |
Why?
| | Schools | 1 | 2022 | 452 | 0.040 |
Why?
| | Minority Groups | 1 | 2000 | 277 | 0.040 |
Why?
| | Health Education | 1 | 2022 | 357 | 0.040 |
Why?
| | Mental Health | 1 | 2025 | 776 | 0.030 |
Why?
| | Body Mass Index | 3 | 2013 | 2420 | 0.030 |
Why?
| | Risk | 2 | 2012 | 909 | 0.030 |
Why?
| | Child | 4 | 2025 | 22537 | 0.030 |
Why?
| | Menopause | 2 | 2011 | 319 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 292 | 0.030 |
Why?
| | Postmenopause | 2 | 2009 | 391 | 0.030 |
Why?
| | Pregnancy | 3 | 2022 | 7180 | 0.030 |
Why?
| | Medicaid | 1 | 2021 | 461 | 0.030 |
Why?
| | Intersectoral Collaboration | 1 | 2017 | 62 | 0.030 |
Why?
| | Data Collection | 2 | 2014 | 633 | 0.030 |
Why?
| | Risk-Taking | 1 | 1999 | 323 | 0.030 |
Why?
| | Patient Selection | 1 | 2000 | 719 | 0.030 |
Why?
| | Cost of Illness | 1 | 2019 | 319 | 0.030 |
Why?
| | Urban Population | 1 | 1999 | 490 | 0.030 |
Why?
| | Health Care Costs | 1 | 1999 | 421 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 394 | 0.030 |
Why?
| | Child, Preschool | 2 | 2025 | 11774 | 0.030 |
Why?
| | Health Status Disparities | 1 | 2019 | 321 | 0.030 |
Why?
| | Prejudice | 1 | 2015 | 60 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2017 | 402 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 881 | 0.030 |
Why?
| | Organizational Innovation | 1 | 2015 | 120 | 0.030 |
Why?
| | Cancer Care Facilities | 1 | 2015 | 48 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 487 | 0.030 |
Why?
| | Poverty Areas | 1 | 2014 | 42 | 0.030 |
Why?
| | Poverty | 1 | 2018 | 523 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 197 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2015 | 238 | 0.030 |
Why?
| | Program Development | 1 | 2015 | 369 | 0.020 |
Why?
| | Insurance, Health | 1 | 2015 | 301 | 0.020 |
Why?
| | Prevalence | 2 | 2010 | 2815 | 0.020 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2011 | 52 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2011 | 62 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 490 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2015 | 8243 | 0.020 |
Why?
| | Adolescent | 3 | 2019 | 22281 | 0.020 |
Why?
| | Population Surveillance | 1 | 2013 | 483 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2011 | 356 | 0.020 |
Why?
| | Premenopause | 1 | 2009 | 123 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 704 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2013 | 1461 | 0.020 |
Why?
| | Body Size | 1 | 2009 | 95 | 0.020 |
Why?
| | Decision Making | 1 | 2015 | 974 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 89 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 527 | 0.020 |
Why?
| | Women's Health | 1 | 2009 | 308 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 569 | 0.020 |
Why?
| | Societies, Medical | 1 | 2011 | 886 | 0.020 |
Why?
| | Motor Activity | 1 | 2011 | 720 | 0.020 |
Why?
| | Attitude to Health | 1 | 2009 | 434 | 0.010 |
Why?
| | Risk Assessment | 1 | 2015 | 3637 | 0.010 |
Why?
| | Diabetes, Gestational | 1 | 2007 | 321 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 17009 | 0.010 |
Why?
| | Cultural Characteristics | 1 | 2000 | 70 | 0.010 |
Why?
| | Language | 1 | 2000 | 321 | 0.010 |
Why?
|
|
Risendal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|